You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Mental health, behavioural and neurodevelopmental conditions
  5. Dementia

Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

  • Technology appraisal guidance
  • Reference number: TA217
  • Published:  23 March 2011
  • Last updated:  20 June 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

NICE guidance extends recommendations on Alzheimer's drugs

2011/047 NICE guidance extends recommendations on Alzheimer's drugs

2011/047 NICE guidance extends recommendations on Alzheimer's drugs2011/047 NICE guidance extends recommendations on Alzheimer's drugs
18 March 2011
(89.17 Kb 25 sec @ 28.8Kbps)
Adobe Acrobat reader required.

 Adobe Acrobat reader required.

Back to top